Jessica Fye
Stock Analyst at JP Morgan
(1.76)
# 1289
Out of 5,270 analysts
211
Total ratings
58.33%
Success rate
10.90%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals | Maintains: Overweight | 200 209 | 140.19 | 49.08% | 4 | Feb 26, 2025 | |
Ascendis Pharma | Maintains: Overweight | 167 168 | 151.76 | 10.7% | 9 | Feb 13, 2025 | |
Insmed | Maintains: Overweight | 83 92 | 76.19 | 20.75% | 7 | Feb 7, 2025 | |
Denali Therapeutics | Maintains: Overweight | 28 24 | 15.12 | 58.73% | 5 | Jan 7, 2025 | |
Vertex Pharmaceutica... | Maintains: Overweight | 503 500 | 483.3 | 3.46% | 7 | Dec 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 59 45 | 30.27 | 48.66% | 11 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 124 122 | 111.4 | 9.52% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 81 89 | 131.27 | -32.2% | 7 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 110 109 | 71.05 | 53.41% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 65 71 | 70.18 | 1.17% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 32 26 | 34.1 | -23.75% | 6 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 200 235 | n/a | n/a | 4 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 30 | 10.15 | 195.57% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 52 57 | 57.92 | -1.59% | 9 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 50 55 | 32.54 | 69.02% | 2 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 248 280 | 243.64 | 14.92% | 3 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 70 66 | 28.89 | 128.45% | 4 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 47 54 | 34.11 | 58.31% | 5 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 31 39 | 45.94 | -15.11% | 3 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 280 300 | 310.1 | -3.26% | 11 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 13 | 7.38 | 76.15% | 4 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 14 16 | n/a | n/a | 5 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 15 17 | 18.36 | -7.41% | 3 | Mar 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 25 45 | n/a | n/a | 4 | Dec 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 217 330 | n/a | n/a | 1 | Dec 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Underweight | n/a | n/a | n/a | 7 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Underweight | n/a | n/a | n/a | 2 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Neutral | n/a | n/a | n/a | 9 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Underweight | n/a | n/a | n/a | 3 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Overweight | 10 | 8.54 | 17.1% | 3 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 30 | n/a | n/a | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 65 76 | 32.95 | 130.65% | 2 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 154 150 | n/a | n/a | 2 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 204 240 | 4.62 | 5094.81% | 2 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 150 70 | n/a | n/a | 2 | Jan 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 2 | Aug 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 256 112 | n/a | n/a | 2 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 3 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 22 | 1.27 | 1632.28% | 1 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 7 | 0.3 | 2233.33% | 2 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 32 27 | 13.55 | 99.26% | 5 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 9 8 | n/a | n/a | 4 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 9 8 | n/a | n/a | 2 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 58 | n/a | n/a | 2 | Jan 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Mar 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 3 | Feb 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Feb 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Feb 8, 2018 |